angioplasty

Tony Gershlick Tony Gershlick, University of Leicester Adnan Kastrati, Deutsches Herzzentrum, Munich Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing deat

Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,

Warren Cantor Tony Gershlick REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction Warren Cantor, University of Toronto COMMENT: Tony Gershlick, Leicester

Uwe Zeymer REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida UWE ZEYMER, Herzzentrum Ludwigshafen, Germany The gl

REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LESLEE SHAW, Emory University, Atlanta COMMENT: DANI

HARVEY WHITE, Auckland City Hospital REFERENCE: ACC 2007 & N Engl J Med 356: March 2007 The finding from the COURAGE trial: that angioplasty adds no benefits to optimal medical therapy alone for

FELIPE ALBUQUERQUE, Barrow Neurological Institute, Phoenix REFERENCE: Abstract 102 The Wingspan stent is a new approach to keeping open the atherosclerotic intracranial vessels of stroke and TIA patie

Judith Hochman Timothy Gardner Girish Mood Marc Cohen Late Opening of Total Occlusion: No Benefit from PCI for Patients with STEMI REFERENCE: LBCT II News Conference November 14th 2006 JUDITH HOCHMAN,

CHRISTIAN SPAULDING, Cochin Hospital, Paris REFERENCE: N Engl J Med 2006;355:1093, 1105,1169 Two leading articles in the same edition of the New England Journal of Medicine have investigated the use o

Gilles Montalescot Freek Verheugt Angioplasty: Four-Continent RIVIERA Study Identifies “Real World” Modifiable Factors Which Affect Outcome REFERENCE: Abstract 3413, “Hot Line II&rdq

Shamir Mehta Keith Fox Petr Widimsky Gerrit Veen OASIS 5 & 6: Fondaparinux Anticoagulation: Benefit on Mortality, Events and Bleeding in Acute Coronary Syndromes and ST-Elevation Myocardial Infarc

David Wood Magnus Ohman Kenneth Morgan Philip Poole-Wilson EUROACTION Study: Nurse-Led Teams Succeed in Modifying Lifestyle to Reduce Coronary Risks REFERENCE: Abstract 986; Hot Line 1 Session David W

Christian Spaulding, Rene Descartes University American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta Primary PCI is even more effective for treating myocardial infarction

John Hodgson, St. Joseph’s Hospital and Medical Center, Phoenix American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The TYPHOON study from Paris – as report

Frans Van de Werf, University of Leuven Abstract Lancet 367:569-578 Results from a new study just published in the Lancet look into the role of facilitated PCI in patients with ST-elevation acute myoc

Anthony H. Gershlick, Leicester University Abstract: N Engl J Med 2005; 353:2758 If your patient with myocardial infarction has been treated with thrombolysis as primary therapy, and if reperfusion is

Gilles Montalescot The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the find